Trials / Conditions / VHL - Von Hippel-Lindau Syndrome
VHL - Von Hippel-Lindau Syndrome
3 registered clinical trials studyying VHL - Von Hippel-Lindau Syndrome — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau NCT07171905 | IRCCS Ospedale San Raffaele | Phase 2 |
| Not Yet Recruiting | Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau S NCT07275099 | IRCCS Ospedale San Raffaele | — |
| Active Not Recruiting | A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associate NCT03401788 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |